Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Sampling Plans01:23

Sampling Plans

Sampling is a crucial step in analytical chemistry, allowing researchers to collect representative data from a large population. Common sampling methods include random, judgmental, systematic, stratified, and cluster sampling.
Random sampling is a method where each member of the population has an equal chance of being selected for the sample. It involves selecting individuals randomly, often using random number generators or lottery-type methods. For example, when analyzing the properties of a...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bayesian updating of malignant hyperthermia susceptibility using documented triggering anaesthetic exposure.

British journal of anaesthesia·2026
Same author

Scalable ARG-free Detection of Denisovan-mediated Superarchaic Introgression Reveals Heterogeneous Patterns across Populations.

bioRxiv : the preprint server for biology·2026
Same author

Cross-definition GWAS of IBS in 2.8 million individuals reveals cardiometabolic and triglyceride-linked mechanisms.

Gut·2026
Same author

Optimal Reference Panel Design in Ancient DNA Imputation from Coalescent Theory, Simulation, and Real Data Application with an Ancient Reference Panel.

bioRxiv : the preprint server for biology·2026
Same author

A Benchmark of Modern Statistical Phasing Methods.

bioRxiv : the preprint server for biology·2026
Same author

Admixture-informed polygenic risk reporting using the ePRS framework.

Nature communications·2026

Related Experiment Video

Updated: May 23, 2026

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Sampling strategies for rare variant tests in case-control studies.

Sebastian Zöllner1

  • 1Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA. szoellne@umich.edu

European Journal of Human Genetics : EJHG
|April 19, 2012
PubMed
Summary

Selecting family members with affected relatives significantly boosts the power of rare variant tests for common disorders. This approach requires smaller sample sizes compared to random case selection, especially for gene-gene interactions.

More Related Videos

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Related Experiment Videos

Last Updated: May 23, 2026

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Area of Science:

  • Genetics
  • Genomic Medicine
  • Statistical Genetics

Background:

  • Advances in sequencing technologies enable the assessment of rare genetic variations in common diseases.
  • Current methods aggregate rare variants within genes to compare case and control groups.
  • High costs associated with sequencing large cohorts necessitate efficient sample selection strategies.

Purpose of the Study:

  • To evaluate the impact of ascertainment strategies on the statistical power of rare variant association tests.
  • To compare the efficiency of sequencing random cases versus cases with affected family members.
  • To provide guidelines for sample selection based on inheritance models and heritability.

Main Methods:

  • Comparison of statistical power between random case selection and family-ascertained case selection.
  • Quantification of power gains under different genetic models, including multiplicative and additive gene-gene interactions.
  • Analysis of sample size requirements for achieving equivalent power across different ascertainment strategies.

Main Results:

  • Family-ascertained cases require 2-16 fold smaller sample sizes than random cases for equivalent power under multiplicative gene-gene interaction models.
  • The power advantage of family ascertainment can diminish or reverse for additive gene-gene interactions in highly heritable traits.
  • Selecting cases sharing chromosomal regions identical by descent with affected siblings further enhances statistical power.

Conclusions:

  • Study design for rare variant analysis should consider disease heritability and available sample size.
  • Family-based ascertainment is a powerful strategy for increasing the efficiency of rare variant association studies.
  • Targeted selection of cases with affected relatives and shared genetic material optimizes power for detecting disease-associated rare variants.